The purpose of the study is to see if an experimental drug helps to reduces symptoms of progressive multiple sclerosis.
You may be eligible for this study if: you have been diagnosed with a progressive form of MS (getting worse, but not having relapses); you are between the ages of 18 and 65; you can walk at least 20 meters (about 66 feet)(can use a cane or walker) without resting; you have gotten worse over the past 2 years; and you are not taking Ampyra.
Study involves: taking an experimental medicine/placebo, blood draws, MRIs, questionnaires, neurological testing, physical examinations, ecg (a tracing the electrical activity of your heart), tests of thinking speed, pregnancy testing (for women of child-bearing potential), and walk assessment with a fitbit and in the clinic hallway. There are 11 clinic visits over 28 months, each visit lasting between 2 ½ and 5 hours.
Study-related exams, tests and experimental medication provided free of charge.
$50 for each completed study visit